Howard Safir Insider Profile
4 Followers
Howard Safir, Director at Citius Pharmaceuticals, holds ― shares in Citius Pharmaceuticals (Ticker: CTXR), holds 30.84K shares in Verint Systems (Ticker: VRNT), holds 200.00K shares in Secure Point Technologies Inc (Ticker: IMSCQ).
Howard Safir's Trading History
| VRNTVerint Systems | Apr 22, 2021 | ― | Uninformative Buy | ― | $632.49K | |
| IMSCQSecure Point Technologies Inc | Apr 20, 2015 | ― | Informative Buy | 16.00K | $22.00K | |
| WLKRWalker Innovation Inc | ― | ― | ― | ― | ||
| CTXRCitius Pharmaceuticals | ― | Director | ― | ― |
You May Also Like
Howard Safir insider profile FAQ
What is the percentage of profitable transactions made by Howard Safir?
The percentage of profitable transactions made by Howard Safir is 25%.
What is the average return per transaction made by Howard Safir?
The average return per transaction made by Howard Safir is -36.10%.
What stocks does Howard Safir hold?
Howard Safir holds: CTXR, VRNT, IMSCQ, WLKR stocks.
What was Howard Safir's most profitable transaction?
Howard Safir’s most profitable transaction was an Informative Sell of VRNT stock on September 11, 2018. The return on the trade was 3.30%.
What is Howard Safir's role in Citius Pharmaceuticals?
Howard Safir's role in Citius Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
